20 related articles for article (PubMed ID: 8325953)
1. Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System.
Luca E; Zitzmann K; Bornstein S; Kugelmeier P; Beuschlein F; Nölting S; Hantel C
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760571
[TBL] [Abstract][Full Text] [Related]
2. Common tools for pituitary adenomas research: cell lines and primary cells.
Zhu Z; Cui W; Zhu D; Gao N; Zhu Y
Pituitary; 2020 Apr; 23(2):182-188. PubMed ID: 31728905
[TBL] [Abstract][Full Text] [Related]
3. Use of basal and TRH-stimulated plasma growth hormone concentrations to differentiate between primary hypothyroidism and nonthyroidal illness in dogs.
Pijnacker T; Kooistra HS; Vermeulen CF; van der Vinne M; Prins M; Galac S; Mol JA
J Vet Intern Med; 2018 Jul; 32(4):1319-1324. PubMed ID: 29736988
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells.
Aiello A; Cassarino MF; Nanni S; Sesta A; Ferraú F; Grassi C; Losa M; Trimarchi F; Pontecorvi A; Cannavò S; Pecori Giraldi F; Farsetti A
Endocrine; 2018 Jan; 59(1):102-108. PubMed ID: 28447256
[TBL] [Abstract][Full Text] [Related]
5. Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.
Molica P; Nascif SO; Correa-Silva SR; de Sá LB; Vieira JG; Lengyel AM
Pituitary; 2010 Dec; 13(4):315-23. PubMed ID: 20602173
[TBL] [Abstract][Full Text] [Related]
6. Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.
Nascif SO; Senger MH; Ramos-Dias JC; Lengyel AM
J Endocrinol Invest; 2003 Aug; 26(8):733-7. PubMed ID: 14669827
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone synthesis and secretion by a somatomammotroph cell line derived from normal adult pituitary of the rat.
Chomczynski P; Brar A; Frohman LA
Endocrinology; 1988 Nov; 123(5):2276-83. PubMed ID: 2844507
[TBL] [Abstract][Full Text] [Related]
8. Pituitary insulin-like growth factor-I gene expression: regulation by triiodothyronine and growth hormone.
Fagin JA; Fernandez-Mejia C; Melmed S
Endocrinology; 1989 Nov; 125(5):2385-91. PubMed ID: 2791994
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I action on hypothyroid rat pituitary cells: suppression of triiodothyronine-induced growth hormone secretion and messenger ribonucleic acid levels.
Melmed S; Yamashita S
Endocrinology; 1986 Apr; 118(4):1483-90. PubMed ID: 3948790
[TBL] [Abstract][Full Text] [Related]
10. Regulation of growth hormone messenger RNA synthesis by dexamethasone and triiodothyronine. Transcriptional rate and mRNA stability changes in pituitary tumor cells.
Diamond DJ; Goodman HM
J Mol Biol; 1985 Jan; 181(1):41-62. PubMed ID: 3981636
[TBL] [Abstract][Full Text] [Related]
11. Interaction between insulin and thyroid hormone in rat pituitary tumour cells: insulin attenuates tri-iodothyronine-induced growth hormone mRNA levels.
Prager D; Weber MM; Gebremedhin S; Melmed S
J Endocrinol; 1993 Apr; 137(1):107-14. PubMed ID: 8492068
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line.
Chomczynski P; Soszynski PA; Frohman LA
J Clin Endocrinol Metab; 1993 Jul; 77(1):281-5. PubMed ID: 8325953
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]